( billion and net income ofUSD 7.2 bill...)Newly Published Study Reveals Femara Improves Chances for Harder to,Treat Early Breast Cancer Relapse in Postmenopausal Women,Health

billion and net income of USD 7.2 billion. Approximately USD 5.4 billion was invested in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 101,000 associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com.

References

(1). Mauriac L, et al. Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial. Annal of Oncology 2007. Feb 14 online edition

(2). American Cancer Society. Breast Cancer Detailed Guide. How is Breast Cancer Staged? http://www.cancer.org/docroot/CRI/content/CRI_2_4_7x_CRC_Breast_Cancer_PDF.as p. Accessed 23.04.07

(3). National Cancer Institute. Breast Cancer PDQ: Treatment, Health Professional version. http://www.cancer.gov/cancertopics/pdq/treatment/breast/HealthProfessional. Accessed 23.04.07

    (4). Imaginis, the breast cancer reseource.

http://www.imaginis.com/breasthealth/metastatic.asp. Accessed 23.04.07

(5). Thurlimann B et al. Adjuvant letrozole reduces the risk of relapse in postmenopausal women with receptor positive early breast cancer compared with tamoxifen: first results of the BIG 1-98 trial. N Engl J Med, December 2005

    (6). Femara Summary of Product Characteristics. December 2005


    For more information contact:


    Press Office


    Novartis Oncology

    Tel: +44(0)1276-698691


    Sabrina Gallon

    Ruder Finn

    Tel: +44(0)20-7462-8965

    e-mail: 


    Amy Lawrence

    Ruder Finn

    Tel: +44(0)20-7462-8906

    e-mail: 

'"/>




Page: 1 2 3 4 5
Related medicine technology :

1. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
2. Newly Published Data from Large Study Support Cardiovascular Safety of Avandia (Rosiglitazone Maleate)
3. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
4. Adding Thalidomide to Standard Therapy Improves Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75
5. New Analysis of Data from WHI Provides Reassurance With Respect to Coronary Heart Disease For Newly Menopausal Women Considering Hormone Therapy
6. ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03) Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival Advantage for Patients with Multiple Myeloma
7. MRI Detects Cancers in the Opposite Breast of Women Newly Diagnosed with Breast Cancer
8. Nymox Announces Positive Results from Newly Completed Long-term Study of NX-1207 for Benign Prostatic Hyperplasia
9. Newly Released Canadian Data Links Vaccines with Pervasive Developmental Disorder
10. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
11. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine